Surat utang korporasi
Berikut adalah daftar obligasi AbbVie, Inc., diurutkan berdasarkan imbal hasil hingga jatuh tempo. Investor sering memilih obligasi perusahaan karena stabilitasnya yang lebih tinggi saat terjadi volatilitas di pasar. Pelajari harga, imbal hasil, dan statistik lainnya untuk menemukan investasi yang andal.
Simbol | YTM % | Volume | Harga % | Kupon % | Tanggal Jatuh Tempo | Jumlah yang belum dibayar | Nilai nominal | Jumlah denominasi minimum | Penerbit |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,40% | 12 K | 83,25% | 4,850% | 2044-06-15 | 65,23 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,38% | 124 K | 81,98% | 4,625% | 2042-10-01 | 67,49 M USD | 1.000,00 USD | 2.000,00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,79% | 250 K | 91,22% | 4,550% | 2035-03-15 | 107,65 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| 5,69% | 3,97 M | 96,89% | 5,500% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,62% | 2,64 M | 97,24% | 5,400% | 2054-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,59% | 7,57 M | 100,25% | 5,600% | 2055-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,58% | 2,94 M | 82,78% | 4,250% | 2049-11-21 | 5,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,56% | 0 | 86,51% | 4,450% | 2046-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,56% | 6,5 M | 91,17% | 4,875% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,53% | 0 | 90,15% | 4,700% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,51% | 500 K | 91,05% | 4,750% | 2045-03-15 | 827,09 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,48% | 359 K | 92,82% | 4,850% | 2044-06-15 | 1,01 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,45% | 3,9 M | 99,02% | 5,350% | 2044-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,40% | 376 K | 91,68% | 4,625% | 2042-10-01 | 389,22 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,39% | 0 | 89,11% | 4,400% | 2042-11-06 | 2,6 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,14% | 6,71 M | 89,19% | 4,050% | 2039-11-21 | 4 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,85% | 0 | 95,53% | 4,300% | 2036-05-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,78% | 0 | 97,88% | 4,500% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,77% | 317 K | 103,31% | 5,200% | 2035-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,76% | 12,9 M | 98,48% | 4,550% | 2035-03-15 | 1,68 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,65% | 5,01 M | 102,74% | 5,050% | 2034-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,19% | 1,27 M | 103,40% | 4,950% | 2031-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,09% | 5,16 M | 102,94% | 4,875% | 2030-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,97% | 7,55 M | 97,29% | 3,200% | 2029-11-21 | 5,44 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,92% | 17,19 M | 102,60% | 4,800% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,86% | 0 | 99,83% | 3,200% | 2026-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,83% | 2,69 M | 101,11% | 4,250% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,81% | 7,01 M | 101,06% | 4,800% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,78% | 11,91 M | 99,36% | 2,950% | 2026-11-21 | 3,99 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,77% | 804 K | 101,68% | 4,650% | 2028-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,69% | 0 | 97,24% | 2,625% | 2028-11-15 | 72,11 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,58% | 0 | 95,51% | 2,125% | 2029-06-01 | 36,46 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
| 3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 2,98% | 0 | 90,94% | 1,250% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,60% | 0 | 98,50% | 2,125% | 2029-06-01 | 506,09 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 2,54% | 0 | 98,88% | 2,125% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,48% | 0 | 100,39% | 2,625% | 2028-11-15 | 427,79 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,39% | 0 | 97,17% | 0,750% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| −5,92% | 0 | 98,80% | 2,950% | 2026-11-21 | 9,24 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| — | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |